Generated by AI
PRF Technologies Ltd. is a specialty pharmaceutical company focused on reformulating established therapeutics for clinical use. Its current portfolio centers on post-surgical pain management and localized drug-delivery solutions, including PRF-110, an oil-based formulation designed for direct application into the surgical wound bed to provide sustained analgesia, and OcuRing-K, a bio-erodible implant developed for use in cataract surgery. The company operates in the healthcare sector with an emphasis on developing proprietary treatment options that target specific surgical settings and recovery needs. Headquartered in Tel Aviv, Israel, PRF Technologies also maintains activity in advanced drug-delivery technologies, supporting its role as a niche player in specialty therapeutics and perioperative care.
Website65 Yigal Alon St.
Tel Aviv, 6744316
Israel
Summary of Sep 16's posts. Generated by AI.
Summary of Jun 25's posts. Generated by AI.
Summary of Jul 23's posts. Generated by AI.
Investors talking about PRFX also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.